Latest News
Fed's Williams sees rates remaining restrictive across 2023
A top US central bank official said that he expected interest rates to rise "somewhat above" 3. 5% and to remain at that level throughout 2023.
London close: Stocks dragged lower as inflation concerns continue to weigh
London stocks finished lower having underperformed throughout the session as traders in London were forced to catch-up with selling on global markets over the bank holiday.
Europe close: Stocks surrender early gains
Most of the main European stock market gauges ended lower on Tuesday, under pressure following the release of better-than-expected US job opening and consumer confidence data which appeared to revive concerns over the near-term inflation picture in the US.
US open: Stocks and Treasuries slip after batch of better-than-expected data
US stocks gave up early gains on Tuesday adding to losses in the previous session, despite the release of a batch of mostly better-than-expected economic data.
FTSE 100 movers: Bunzl in the red; Dechra gains on acquisition
London’s FTSE 100 was down 0. 4% at 7,397. 80 in afternoon trade on Tuesday.
US consumer confidence improves in August - Conference Board
US consumer confidence improved more than expected in August, according to data released on Tuesday.
FTSE 250 movers: Polymetal shines; Ascential loses ground
London’s FTSE 250 was up 0. 1% at 19,188. 01 in afternoon trade on Tuesday.
Sector movers: Electricity and Mining shares slump as London traders play catch-up
Electricity stocks and miners' shares dragged on the FTSE 350 as the benchmark played catch up with the selling seen in global markets during the bank holiday the day before.
US job openings rise unexpectedly in July, but quits rate ticks lower
The number of job openings in the US increased a bit last month, even as hiring and the number of so-called 'quits' slipped.
Diurnal to be taken over by Neurocrine Biosciences for £48.3m, shares surge
Diurnal shares surged on Tuesday after it agreed to be taken over by US biotech firm Neurocrine Biosciences for £48. 3m.
US house price growth eases in June - S&P/Case-Shiller
US house price growth eased in June, according to the latest S&P/Case-Shiller national home price index.
German inflation hits highest level in nearly 50 years
German inflation hit its highest level in nearly 50 years in August, according to data released on Tuesday by Destatis.
Best Buy reports smaller-than-expected drop in Q2 LFL sales
Best Buy reported a near halving in profits for its fiscal second quarter amid a slump in sales, although the latter beat analysts' estimates in like-for-like terms.
Wednesday preview: US ADP report, China factory PMI, euro area CPI in focus
Financial markets' focus on Wednesday is likely to be on consultancy ADP's US private sector payrolls report for August.
Roper Technologies to buy Frontline Education in $3.73bn deal
Roper Technologies has agreed to buy Frontline Education from software investment firm Thoma Bravo in a $3. 73bn all-cash deal.
AstraZeneca’s Evusheld approved in Japan for treatment, prevention of Covid-19
AstraZeneca said on Tuesday that its Evusheld long-acting antibody combination has been approved in Japan for the prevention and treatment of Covid-19.
Broker tips: Bango, Bunzl, Made.com
Analysts at Berenberg kept their recommendation for payments technology outfit Bango at 'buy' following its acquisition of rival NTT DOCOMO.
Berenberg reiterates 'buy' on Bango after DOCOMO Digital acquisition
Analysts at Berenberg kept their recommendation for payments technology outfit Bango at 'buy' following its acquisition of rival NTT DOCOMO.
Davy upgrades Made.com to 'outperform', shares rally
Shares of Made. com rallied on Tuesday after Davy upgraded its stance on the furniture retailer to ‘outperform’, citing sale potential.
Eurozone confidence drops in August amid rising inflation
Economic confidence in the eurozone fell in August, hitting a 19-month low amid surging inflation, according to data released on Tuesday by the European Commission.